Frederique Ph.D. Menzaghi - 01 Apr 2022 Form 4 Insider Report for Cara Therapeutics, Inc. (TVRD)

Role: Chief Scientific Off,SVP-R&D
Signature: /s/Darren DeStefano, Attorney-in-Fact
Issuer symbol: TVRD
Transactions as of: 01 Apr 2022
Net transactions value: -$21,247
Form type: 4
Filing time: 05 Apr 2022, 17:49:19 UTC
Previous filing: 01 Mar 2022
Next filing: 23 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CARA	Common Stock	Sale	$21,247	-1,784	-1%	$11.91	169,781	01 Apr 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on April 1, 2021, and does not represent a discretionary trade by the Reporting Person.

Content

This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on April 1, 2021, and does not represent a discretionary trade by the Reporting Person.